Search research articles
Contact Us
Filters
Showing results (1-10 of 43) with videos related to
Page
of 5
Sort By:
Cell Cycle (Georgetown, Tex.)
|
April 23, 2005
Activation of Bax by BH3 domains during apoptosis: the unfolding of a deadly plot
Philippe Juin, Pierre François Cartron, François M Vallette
Critical Reviews in Oncology/Hematology
|
August 6, 2010
Resistance to HER2 inhibitors: is addition better than substitution? Rationale for the hypothetical concept of drug sedimentation
Mario Campone, Philippe Juin, Fabrice André, et al.
Anticancer Research
|
October 13, 2012
Regulation of cancer cell survival by BCL2 family members upon prolonged mitotic arrest: opportunities for anticancer therapy
Sophie Barillé-Nion, Nourdine Bah, Eloïse Véquaud, et al.
European Journal of Medicinal Chemistry
|
March 20, 2012
Structure-activity relationship of selected polyphenol derivatives as inhibitors of Bax/Bcl-xL interaction
Duc Duy Vo, Fabien Gautier, Philippe Juin, et al.
Nature Reviews. Cancer
|
June 21, 2013
Decoding and unlocking the BCL-2 dependency of cancer cells
Philippe Juin, Olivier Geneste, Fabien Gautier, et al.
Leukemia Research
|
January 17, 2007
HA14-1, a small molecule inhibitor of Bcl-2, bypasses chemoresistance in leukaemia cells
Lisa Oliver, Béatrice Mahé, René Gréé, et al.
Breast Cancer Research and Treatment
|
December 19, 2015
Survivin contributes to DNA repair by homologous recombination in breast cancer cells
Eloïse Véquaud, Grégoire Desplanques, Pascal Jézéquel, et al.
Bulletin Du Cancer
|
May 23, 2012
[Tumor resistance to HER2 inhibitors: the drug sedimentation concept]
Mario Campone, Jean-Sébastien Frenel, Fabrice André, et al.
Cell Cycle (Georgetown, Tex.)
|
August 27, 2013
Protect and serve: Bcl-2 proteins as guardians and rulers of cancer cell survival
Frédérique Braun, Sophie de Carné Trécesson, Joséphine Bertin-Ciftci, et al.
Expert Review of Anticancer Therapy
|
August 26, 2003
Impact of proapoptotic proteins Bax and Bak in tumor progression and response to treatment
Pierre-François Cartron, Philippe Juin, Lisa Oliver, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 43) with videos related to
Sort By:
Page
of 5
Cell Cycle (Georgetown, Tex.)
|
April 23, 2005
Activation of Bax by BH3 domains during apoptosis: the unfolding of a deadly plot
Philippe Juin, Pierre François Cartron, François M Vallette
Critical Reviews in Oncology/Hematology
|
August 6, 2010
Resistance to HER2 inhibitors: is addition better than substitution? Rationale for the hypothetical concept of drug sedimentation
Mario Campone, Philippe Juin, Fabrice André, et al.
Anticancer Research
|
October 13, 2012
Regulation of cancer cell survival by BCL2 family members upon prolonged mitotic arrest: opportunities for anticancer therapy
Sophie Barillé-Nion, Nourdine Bah, Eloïse Véquaud, et al.
European Journal of Medicinal Chemistry
|
March 20, 2012
Structure-activity relationship of selected polyphenol derivatives as inhibitors of Bax/Bcl-xL interaction
Duc Duy Vo, Fabien Gautier, Philippe Juin, et al.
Nature Reviews. Cancer
|
June 21, 2013
Decoding and unlocking the BCL-2 dependency of cancer cells
Philippe Juin, Olivier Geneste, Fabien Gautier, et al.
Leukemia Research
|
January 17, 2007
HA14-1, a small molecule inhibitor of Bcl-2, bypasses chemoresistance in leukaemia cells
Lisa Oliver, Béatrice Mahé, René Gréé, et al.
Breast Cancer Research and Treatment
|
December 19, 2015
Survivin contributes to DNA repair by homologous recombination in breast cancer cells
Eloïse Véquaud, Grégoire Desplanques, Pascal Jézéquel, et al.
Bulletin Du Cancer
|
May 23, 2012
[Tumor resistance to HER2 inhibitors: the drug sedimentation concept]
Mario Campone, Jean-Sébastien Frenel, Fabrice André, et al.
Cell Cycle (Georgetown, Tex.)
|
August 27, 2013
Protect and serve: Bcl-2 proteins as guardians and rulers of cancer cell survival
Frédérique Braun, Sophie de Carné Trécesson, Joséphine Bertin-Ciftci, et al.
Expert Review of Anticancer Therapy
|
August 26, 2003
Impact of proapoptotic proteins Bax and Bak in tumor progression and response to treatment
Pierre-François Cartron, Philippe Juin, Lisa Oliver, et al.
Page
of 5